Stay updated on Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.

Latest updates to the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page's revision tag has been updated from v3.5.3 to v3.5.4, indicating a recent behind-the-scenes update. This change affects only metadata and does not modify the study content or results presented on the page.SummaryDifference0.0%

- Check9 days agoChange DetectedTaoyuan District, Taiwan was replaced with Taoyuan, Taiwan in the study locations, with Taoyuan added and Taoyuan District removed. This update reflects a city-level designation in the site list to more accurately identify the participating location.SummaryDifference0.0%

- Check16 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3. This indicates a build/version update for the page.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. No visible changes to study details or user-facing content.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 across the site.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed on the page as part of the site version update.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.